Effects of Body Composition on Vascular Health in Females with a Healthy Body Weight

NCT ID: NCT06818500

Last Updated: 2025-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Most of the time, body weight is evaluated by looking at the ratio of your weight to your height. This measurement is called body mass index or BMI. However, BMI does not account for what your body is actually made up of (e.g., body fat versus muscle), which may be more important for determining cardiovascular disease risk. The investigators aim to understand vascular health in females with a "healthy" BMI with differing amounts of body fat and muscle mass. We will have participants come to the lab for two different study visits. At one visit, participants will eat a meal high in fat, and at the other visit, participants will undergo a stress task.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators will recruit females with a BMI in the normal (18.5-24.9 kg/m2) from the Ball State University campus and surrounding communities. Each participant will complete a meal trial and a stress trial in a randomized crossover design. At the meal trial, an intravenous catheter will be inserted and baseline blood sample collected. Then vascular measurements (i.e., flow-mediated dilation, pulse wave analysis, pulse wave velocity) will be performed. Each time vascular measurements are performed, the participants will lie in a quiet area to acclimate prior to beginning. Next, participants will consume a high-fat, Western style meal consisting of two Jimmy Deans Breakfast Bowls (sausage; 68 g fat; 880 kcal). Following completion of the meal, blood samples will also be collected 1, 2, 3, and 4 hours after the meal. Vascular measurements will be repeated 2 and 4 hours after the meal. Blood will be collected and stored as serum in order to measure triglycerides, HDL-C, and intestinal permeability (e.g., lipopolysaccharide binding protein) using commercially available ELISAs.

At the stress trial, an intravenous catheter will be inserted and baseline blood sample collected. Then vascular measurements (i.e., flow-mediated dilation, pulse wave analysis, pulse wave velocity) will be performed. Each time vascular measurements are performed, the participants will lie in a quiet area to acclimate prior to beginning. Next, participants will undergo the stress task. Then, blood samples will be collected at 10, 60, and 90 minutes after the stress task. Blood will be collected and stored as serum in order to measure epinephrine and inflammatory markers. Vascular measurements will also be repeated 10 and 90 minutes after the stress task.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Normal-weight Obesity BMI Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

We are studying human physiology of cardiovascular health in females with a normal BMI. We will not be using any drug interventions. Instead, participants will eat a high-fat meal at one visit and complete a stress task at the other visit. Vascular responses will be assessed.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High-fat meal trial

During the "High-fat meal trial", participants will report fasted and consume two Jimmy Dean's breakfast bowls.

Group Type EXPERIMENTAL

high-fat meal

Intervention Type OTHER

Participants will report fasted and consume two Jimmy Dean breakfast bowls (sausage).

Stress trial

During the "Stress trial", participants will report fasted and undergo a stress task where they may experience mental stress.

Group Type EXPERIMENTAL

Stress

Intervention Type OTHER

Participants will report fasted and undergo a mental stress task.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

high-fat meal

Participants will report fasted and consume two Jimmy Dean breakfast bowls (sausage).

Intervention Type OTHER

Stress

Participants will report fasted and undergo a mental stress task.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* You are 18-50 years old
* Your biological sex is female
* BMI is in "normal" category (18.5-24.9 kg/m2) - this BMI requirement is due to our research aims
* You are not pregnant or expecting to become pregnant
* You are not postmenopausal
* You have not been diagnosed with a cardiometabolic condition (e.g., cardiovascular disease, type 2 diabetes)
* You have not been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
* You do not regularly take anti-inflammatory drugs (more than 2x week) or are able to temporarily suspend use of anti-inflammatory drugs.
* You do not use lipid-lowering drugs (e.g., statins), glucose-lowering drugs (e.g., metformin) tobacco products, or any illicit drugs
* You do not have a pacemaker.
* You do not have dietary restrictions prohibiting you from eating the provided meal (e.g., vegan/vegetarian diets, gluten-free diet, relevant food allergies).
* You are able to stay in the supine position in the dark for at least 10 minutes

Exclusion Criteria

* You are not 18-50 years old
* Your biological sex is not female
* Your BMI is not in the "normal" category (18.5-24.9 kg/m2) - this BMI requirement is due to our research aims
* You are pregnant or expecting to become pregnant (females only)
* You are postmenopausal
* You have been diagnosed with a cardiometabolic condition (e.g., cardiovascular disease, type 2 diabetes)
* You have been diagnosed with a chronic inflammatory condition (e.g., rheumatoid arthritis, inflammatory bowel disease).
* You regularly take anti-inflammatory drugs (more than 2x week) or are unable to temporarily suspend use of anti-inflammatory drugs.
* You use lipid-lowering drugs (e.g., statins), glucose-lowering drugs (e.g., metformin) tobacco products, or any illicit drugs
* You have a pacemaker.
* You do have dietary restrictions prohibiting you from eating the provided meal (e.g., vegan/vegetarian diets, gluten-free diet, relevant food allergies).
* You are unable to stay in the supine position in the dark for at least 10 minutes
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ball State University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ball State University- Nutrition Assessment Lab

Muncie, Indiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bryant H Keirns, PhD

Role: CONTACT

7652858356

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bryant H Keirns, PhD

Role: primary

7652858356

Bryant H Keirns, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2201237-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cross Validation of Body Composition Measurement
NCT06453564 ENROLLING_BY_INVITATION